FDA Approved: LYSODREN — Supplemental Application (ESTEVE PHARMACEUTICALS, S.A.)

View source ↗

Summary

The FDA approved a supplemental application for LYSODREN (mitotane) filed by ESTEVE Pharmaceuticals, S.A.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenocortical Carcinoma

Drugs mentioned

• LYSODREN (MITOTANE)

Snippet

SUPPL AP for LYSODREN (MITOTANE)